After systemic IL-17A blockade, the expression of those inflammatory mediators (IL36G, S100A8, DEFB4A, and DEFB4B) was decreased in posttreatment psoriasis lesional skin KCs compared to pretreatment psoriasis lesional skin KCs (Figure 6A, p < 0.05). This evidence concerns the gene DEFB4B and psoriasis.